Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H31ClFN7O |
InChIKeyVWELCPLMPPEKOL-UHFFFAOYSA-N |
CAS Registry1054315-48-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 09 Oct 2008 |